Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaActive, not recruitingPhase 22026-09-30NCT01638546

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Case Western Reserve UniversityClevelandUnited States219
Emory University Hospital/Winship Cancer InstituteAtlantaUnited States299
Johns Hopkins Bayview Medical CenterBaltimoreUnited States27
Johns Hopkins University/Sidney Kimmel Cancer CenterBaltimoreUnited States238
Memorial Sloan Kettering Basking RidgeBasking RidgeUnited States189
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Memorial Sloan Kettering CommackCommackUnited States189
Memorial Sloan Kettering NassauUniondaleUnited States193
Memorial Sloan Kettering Sleepy HollowSleepy HollowUnited States12
Moffitt Cancer CenterTampaUnited States523
UNC Lineberger Comprehensive Cancer CenterChapel HillUnited States243
UT MD Anderson Cancer CenterHoustonUnited States204
VCU Massey Comprehensive Cancer CenterRichmondUnited States273
Washington University School of MedicineSt LouisUnited States895